Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
TAAT Global Alternatives Inc
C.TAAT
Alternate Symbol(s):
TOBAF
Healthcare
Household & Personal Products
TAAT Global Alternatives Inc. is a vertically integrated consumer product and distribution company. The Company develops, manufactures, and distributes alternative product categories, such as tobacco and reduced-risk alternatives, hemp, kratom, and other emerging consumer packaged goods (CPG) segments. The Company operates through two segments: the sale of non-tobacco and tobacco products. The...
Company is developing nicotine-free and tobacco-free alternatives to traditional cigarettes. The Company utilizes a proprietary, patent-pending process (including a patent-pending refinement technique) with a blend of all-natural ingredients to provide smokers aged above 21 with an alternative to traditional cigarettes that do not contain nicotine or tobacco. The Company has facilities to include a processing plant in Nevada as well as a distribution center in Canton, Ohio, leveraging existing retail shelf space and pipelines into national wholesale channels.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
CSE:TAAT - Post Discussion
TAAT Global Alternatives Inc
> Anything?
New Post
View:
Discussion
List
(15)
•••
granniegrant
X
View Profile
View Bullboard History
Post by
granniegrant
on Mar 22, 2021 9:22am
Anything?
Is there not something that management could talk about? Maybe something is amiss within?
(0)
•••
TheFlowTrader
X
View Profile
View Bullboard History
Comment by
TheFlowTrader
on Mar 22, 2021 10:22am
A month ago TAAT closed at $5.40 and now it's struggling to stay above $4.00. The question is why. Management has gone quiet but investors would like them to be telling us what is happening on the ground with the launch. This lack of news is making investors nervous and that causes the SP to retreat. If I was a conspiracy theorist, I'd start to wonder if
...more
(237)
•••
Happytaater202
X
View Profile
View Bullboard History
Comment by
Happytaater202
on Mar 22, 2021 11:33am
Q1 which is comn up very soon end of March will give us a glimpse of the numbers for 1st Quarter...but again it ain't gonna be a whole lot of revenue or sales but at least it will be something for us all to chew on. I believe that it will be okay numbers but not great numbers imo! Q2 will have a much better picture of things and where this company is headed with regards too $$$...Crossmark
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Why Your Eyes Should be on this Oil & Gas Company in 2025
Electrum Discovery Corp Announces Positive Results from IP Survey, Further Validates Bambino Anomaly
New research report on Nextech3D.AI by H.C. Wainwright & Co.
BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
A potential breakthrough in spinal cord and optic nerve injury treatment